Design and investigation of CRISPRi tools based on dCasMINI protein

doi:10.16352/j.issn.1001-6325.2024.06.0821

Abstract

Abstract: Objective To explore the design of CRISPR interference (CRISPRi) tools based on the deactivated CasMINI (dCasMINI) protein and to evaluate their transcriptional inhibition effects. Methods The tetracycline-on (tet-on) system, flow cytometry, and quantitative reverse transcription polymerase chain reaction (RT-qPCR) were used to evaluate the transcriptional inhibition effects of dCasMINI system in mammalian cells at three level-plasmid genes, exogenous genomic loci, and endogenous genomic loci. Additionally, six dCasMINI-CRISPRi tools (dCasMINI, dCasMINI-ZIM3 KRAB, dCasMINI-KRAB-MeCP2, dCasMINI-ZNF324 KRAB, dCasMINI-3x KRAB, and dCasMINI-Com-KRAB-MECP2) were designed and compared for their transcriptional inhibition effects along with single guide RNA (sgRNA) at different positions. Results dCasMINI, dCasMINI-ZIM3 KRAB,dCasMINI-KRAB-MeCP2, dCasMINI-ZNF324 KRAB, dCasMINI-3x KRAB, and dCasMINI-Com-KRAB-MeCP2 exhibited varying degrees of transcriptional inhibition on plasmids genes and exogenous genomic genes (P＜0.05). Additionally, dCasMINI-ZIM3 KRAB, dCasMINI-KRAB-MeCP2, dCasMINI-ZNF324 KRAB, and dCasMINI-Com-KRAB-MeCP2 demonstrated different levels of transcriptional inhibition on endogenous genes (P＜0.05). Different positions of sgRNAs showed distinct transcriptional inhibition effects (P＜0.05). Conclusions The CasMINI system can be adapted into various CRISPRi tools for gene knockdown studies, with potential applications in various scenarios such as epigenetic gene editing in primary cells, in vivo screening, and clinical therapy in the future.

Key words: CRISPR interference, dCasMINI, knock-down, tetracycline-on (tet-on)

CLC Number:

CHEN Xinwen, CAO Jiaxuan, RAO Shuquan. Design and investigation of CRISPRi tools based on dCasMINI protein[J]. Basic & Clinical Medicine, 2024, 44(6): 821-827.

References 12

[1]	Jinek M, Chylinski K, Fonfara I, et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity[J]. Science, 2012, 337: 816-821.
[2]	Qi LS, Larson MH, Gilbert LA, et al. Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression[J]. Cell, 2013, 152: 1173-1183.
[3]	Gilbert LA, Larson MH, Morsut L, et al. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes[J]. Cell, 2013, 154: 442-451.
[4]	Zalatan JG, Lee ME, Almeida R, et al. Engineering complex synthetic transcriptional programs with CRISPR RNA scaffolds[J]. Cell, 2015, 160: 339-350.
[5]	Campa CC, Weisbach NR, Santinha AJ, et al. Multiplexed genome engineering by Cas12a and CRISPR arrays encoded on single transcripts[J]. Nat Methods, 2019, 16: 887-893.
[6]	Alerasool N, Segal D, Lee H, et al. An efficient KRAB domain for CRISPRi applications in human cells[J]. Nat Methods, 2020, 17: 1093-1096.
[7]	Xu X, Chemparathy A, Zeng L, et al. Engineered miniature CRISPR-Cas system for mammalian genome regula-tion and editing[J]. Mol Cell, 2021, 81: 4333-4345.
[8]	Harrington LB, Burstein D, Chen JS, et al. Programmed DNA destruction by miniature CRISPR-Cas14 enzymes[J]. Science, 2018, 362: 839-842.
[9]	Yeo NC, Chavez A, Lance-Byrne A, et al. An enhanced CRISPR repressor for targeted mammalian gene regulation[J]. Nat Methods, 2018, 15: 611-616.
[10]	Jensen KT, Fløe L, Petersen TS, et al. Chromatin accessibility and guide sequence secondary structure affect CRISPR-Cas9 gene editing efficiency[J]. FEBS Lett, 2017,591: 1892-1901.
[11]	Takeda SN, Nakagawa R, Okazaki S, et al. Structure of the miniature type V-F CRISPR-Cas effector enzyme[J]. Mol Cell, 2021, 81: 558-570.
[12]	Kang K, Huang L, Li Q, et al. An improved Tet-on system in microRNA overexpression and CRISPR/Cas9-mediated gene editing[J]. J Anim Sci Biotechnol, 2019, 10: 43. doi: 10.1186/s40104-019-0354-5.

[1]	WANG Zeying, LIU Zhi, TAI Yu, YANG Zhongbin, SU Yan. Progress on the role of transketolase in occurrence and treatment of diabetes and its complications [J]. Basic & Clinical Medicine, 2024, 44(7): 1023-1028.
[2]	YU Zhixin, MANG Xinyu, ZOU Dingfeng, MIAO Shiying, SONG Wei, LI Kai. Effects of intraperitoneal injection of busulfan on metabolic characteristics of spermatogonial stem cells [J]. Basic & Clinical Medicine, 2024, 44(6): 793-799.
[3]	YANG Hanyi, NING Jiayi, WANG Xiaolan, ZHANG Yimeng, XIE Tingke, CHEN Yixuan, HAN Jing. Melatonin inhibits H₂O₂-induced oxidative stress and apoptosis marker protein expression in human umbilical vein endothelial cells [J]. Basic & Clinical Medicine, 2024, 44(5): 645-650.
[4]	WANG Tingting, XIAO Ning, LIN Dianxin, DONG Haitao. Allicin inhibits the proliferation of oral cancer cells line CAL27 [J]. Basic & Clinical Medicine, 2024, 44(5): 673-676.
[5]	WANG Tingting, GUO Dan, LU Junyang, XU Lai, DONG Haitao, LIN Dianxin, XIAO Yi. Analysis of cell mutation types of colorectal neuroendocrine tumors [J]. Basic & Clinical Medicine, 2024, 44(4): 523-527.
[6]	YANG Chunsheng, WANG Tianxing, ZHANG Tiecheng, WU Hengmin, WANG Baolan. Effects of biological clock gene Bmal1 on the expression of cell cycle-associated genes in chondrocytes [J]. Basic & Clinical Medicine, 2024, 44(4): 496-502.
[7]	GUO Xin, JI Mengdie, WANG Qi, LI Xueyuan, CHEN Yang. Identification of the effect of cisplatin on the transcriptome of human hepatocellular carcinoma cell lines [J]. Basic & Clinical Medicine, 2024, 44(3): 352-360.
[8]	MU Yang, YANG Zhiwen. Dexmedetomidine alleviates TNF-α-induced injury of human neuroblastoma cell line SH-SY5Y through activating AMPK [J]. Basic & Clinical Medicine, 2024, 44(2): 147-153.
[9]	LI Xiang, LI Ye. Research progress on the interaction between autophagy and ferroptosis in non-alcoholic fatty liver disease [J]. Basic & Clinical Medicine, 2023, 43(8): 1294-1298.
[10]	WANG Fan, DENG Yongzhi. Advances on the role and molecular mechanism of microRNAs in cardiac hypertrophy [J]. Basic & Clinical Medicine, 2023, 43(7): 1167-1170.
[11]	YANG Weizhu, LIU Zhong, ZHANG Fenglin, HUANG Yanlin, SUN Jin, TIAN Xinhua. NOX4-mediated oxidative stress is involved in the occurrence of pituitary adenoma hemorrhagic stroke [J]. Basic & Clinical Medicine, 2023, 43(7): 1040-1044.
[12]	ZHANG Ying, FANG Hongjuan. Cultivation of medical student’s science popularization ability in teaching of pharmacy [J]. Basic & Clinical Medicine, 2023, 43(7): 1175-1178.
[13]	HE Jiayin, YANG Jiabin, CHEN Zhongyang, MA Yanni, YU Jia. Enolase1 regulates the self-renewal ability of human embryonic stem cells by influencing mRNA localization [J]. Basic & Clinical Medicine, 2023, 43(6): 867-874.
[14]	WANG Jiaxin, YU Donglin, YANG Xi, LIU Xuehui, LYU Xiang. Ikzf1 promotes terminal differentiation of mouse fetal liver derived erythroid cells [J]. Basic & Clinical Medicine, 2023, 43(6): 916-922.
[15]	YAN Jiaqi, WANG Siqi, WANG Zheng, LI Jun. Coptis alkaloids improve gluconeogenesis and lipid accumulation in mouse primary hepatocytes [J]. Basic & Clinical Medicine, 2023, 43(6): 923-930.